Table 4.
Association Between Sleep Stage and T Lymphocyte Subsets in Virally Suppressed Men Living With HIV
| CD4+ count (cells/mm3) |
CD8+ count (cells/mm3) |
CD4+/CD8+ ratio | |||||||
|---|---|---|---|---|---|---|---|---|---|
| β | 95% CI | P-value | β | 95% CI | P-value | β | 95% CI | P-value | |
| N1 sleep duration (per hour decrease) |
−28.7 | (−80.9, 23.5) | 0.28 | 39.2 | (−30.5, 108.9) | 0.27 | −6.5% | (−14.3, 2.0%) | 0.13 |
| N2 sleep duration (per hour decrease) |
1.2 | (28.7, −31.2) | 0.94 | 12.0 | (−27.9, 52.0) | 0.56 | −3.5% | (−8.1, 1.5%) | 0.17 |
| N3 sleep duration (per hour decrease) |
53.2 | (−37.0, 143.4) | 0.25 | 15.4 | (−105.3, 136.1) | 0.80 | 3.9% | (−10.6, 20.9%) | 0.62 |
| REM sleep duration (per hour decrease) | 11.5 | (−59.2, 82.3) | 0.75 | 113.3 | (19.8, 206.9) | 0.02 | −15.8% | (−25.1, −5.4%) | 0.006 |
REM, rapid eye movement sleep.
Results of multivariable linear regression modeling T lymphocyte populations by sleep stage duration (N = 288). The values reported are the effects for each additional hour decrease in time spent in a particular stage of sleep. All models include adjustment for age, race, body mass index, depressive symptoms, antidepressant use, and non-nucleoside reverse transcriptase inhibitor use.